Not yet open
Esketamine Nasal Spray alone for treatment-resistant depression
About the trial
Study status
Not recruiting
Eligibility
Condition(s)
Depressive disorder
Age range
18—65
Biological sex
All
Trial commitments
- You will need to be able to self-administer a nasal spray.